Dr Shabbir Moochhala

Consultant Nephrologist

Digestive Health

Sub-specialties: Renal Medicine, Chronic Kidney Disease, Hypertension, Electrolyte Disorders, Rare Kidney Diseases, Kidney Stone Prevention, Nephrology, Kidney Disease.

Overview

bookings.digestivehealth@onewelbeck.com

02036532009

Overview

Dr Shabbir Moochhala is a Consultant Nephrologist at OneWelbeck. He is very experienced in all aspects of kidney disease, including chronic kidney disease and hypertension, and is also an accredited general physician. Dr Moochhala lectures internationally on rare kidney diseases and runs research trials at the Royal Free Hospital.

About Dr Shabbir Moochhala

Dr Shabbir Moochhala is a Consultant Nephrologist at the Royal Free Hospital in London. He is an expert in treating all types of kidney disease and pathology including acute kidney injury, hypertension, chronic kidney disease, transplantation, and dialysis. He is also an accredited General Physician, with a large breadth of knowledge on common and rare problems. He aims to address all concerns of his patients and isn't restricted to kidney-based concerns.
Dr Moochhala began his medical education in Edinburgh, where he graduated with a First Class honours degree in physiology in addition to his medical degrees. He was then awarded a PhD for his research into rare kidney stone disease in Newcastle upon Tyne. Since then, he has maintained his general and specialist experience, making him an expert in both common disorders and rare renal diseases. His patients say that he has an excellent bedside manner, with a friendly approach.
Dr Moochhala contributes at international level to kidney research and education. He is Principal Investigator for four international clinical trials and is national chair of Rare Disease Groups and an NHS Rare Disease Collaborative Network. He teaches junior doctors and medical students and is a high-profile international lecturer on kidney stone disease and research.
Patient testimonial
"My experience with Dr Moochhala was exceptional. He was courteous, warm and friendly and put me at ease immediately. He discussed my results in detail in a way that I could understand perfectly and when we ended then consultation I felt I had total clarity." [Doctify review, Dec 2023]

Areas of Expertise

Dr Shabbir Moochhala treats various conditions including the following:

  • Renal Medicine
  • Chronic kidney disease
  • Hypertension
  • Electrolyte disorders
  • Rare kidney diseases
  • Kidney stone prevention
  • Nephrology
  • Kidney disease

Some of the treatments and procedures Dr Moochhalaoffers are:

  • Renal biopsy

Additional Information

Awards

  • National lead for NHS Rare Disease Collaborative Network in hyperoxaluria
    Chair of OxalEurope

Memberships

  • Royal College of Physicians of Edinburgh
  • UK Kidney Association
  • European Renal Association
  • European Association of Urology (Section of Urolithiasis)
  • OxalEurope
  • Oxalosis and Hyperoxaluria Foundation

Research Highlights

Dr Shabbir Moochhala

Key Publishications

  • Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Annear N, Barratt J, Bingham C, Chrysochou C, Coward RJ, Game D, Griffin S, Hall M, Johnson S, Kanigicherla D, Karet Frankl F, Kavanagh D, Kerecuk L, Maher ER, Moochhala S, Pinney J, Sayer JA, Simms R, Sinha S, Srivastava S, Tam FWK, Turner AN, Walsh SB, Waters A, Wilson P, Wong E, Taylor CM, Nitsch D, Saleem M, Bockenhauer D, Bramham K, Gale DP
    RaDaR consortium. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. Lancet. 2024 Mar 30;403(10433):1279-1289. doi: 10.1016/S0140-6736(23)02843-X. Epub 2024 Mar 13. PMID: 38492578.
  • Moochhala SH, Worcester EM, Primary hyperoxaluria: the adult nephrologist's point of view, Clinical Kidney Journal, Volume 15, Issue Supplement_1, May 2022, Pages i29–i32, https://doi.org/10.1093/ckj/sfac068
    • Garrelfs S, Frishberg Y, Hulton S, Koren M, O’Riordan W, Cochoat P, Deschenes G, Shasha-Lavsky H, Saland J, van’t Hoff W, Fuster D, Magen D, Moochhala SH et al. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. N Engl J Med 2021
    384:1216-1226. DOI: 10.1056/NEJMoa2021712
  • Moochhala S, Unwin R. Electrolytes and acid–base: common fluid and electrolyte disorders. Medicine (Elsevier) July 2015, Volume 43, Issue 7, Pages 374–380.

Reviews

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.